GFDDX
Price
$92.87
Change
-$0.05 (-0.05%)
Updated
May 9 closing price
Net Assets
8.44B
RNPEX
Price
$62.30
Change
+$0.12 (+0.19%)
Updated
May 9 closing price
Net Assets
142.07B
Ad is loading...

GFDDX vs RNPEX

Header iconGFDDX vs RNPEX Comparison
Open Charts GFDDX vs RNPEXBanner chart's image
Invesco Global R5
Price$92.87
Change-$0.05 (-0.05%)
VolumeN/A
Net Assets8.44B
American Funds New Perspective R4
Price$62.30
Change+$0.12 (+0.19%)
VolumeN/A
Net Assets142.07B
GFDDX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFDDX vs. RNPEX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFDDX is a Buy and RNPEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 142B vs. GFDDX (8.44B). RNPEX pays higher dividends than GFDDX: RNPEX (0.55) vs GFDDX (0.00). GFDDX was incepted earlier than RNPEX: GFDDX (6 years) vs RNPEX (23 years). RNPEX (0.76) and GFDDX (0.74) have similar cost to investors . RNPEX is a more actively managed with annual turnover of: 24.00 vs. GFDDX (7.00). RNPEX has a lower initial minimum investment than GFDDX: RNPEX (250) vs GFDDX (1000000). RNPEX annual gain was more profitable for investors over the last year : 5.27 vs. GFDDX (-8.64). RNPEX return over 5 years is better than : 46.39 vs. GFDDX (8.27).
GFDDXRNPEXGFDDX / RNPEX
Total Expense Ratio0.740.7697%
Annual Report Gross Expense Ratio0.740.7697%
Fund Existence6 years23 years-
Gain YTD-3.4302.282-150%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets8.44B142B6%
Annual Yield % from dividends0.000.55-
Returns for 1 year-8.645.27-164%
Returns for 3 years5.4727.4120%
Returns for 5 years8.2746.3918%
Returns for 10 yearsN/A64.04-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALZN0.660.12
+21.87%
Alzamend Neuro Inc.
REPL7.71-0.06
-0.77%
Replimune Group
ASGN55.69-0.73
-1.29%
ASGN
TOI2.80-0.12
-4.11%
Oncology Institute (The)
AFRM46.41-7.85
-14.47%
Affirm Holdings